Susquehanna International Group, LLP Cor Medix Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.64 - $8.23 $206,752 - $467,464	56,800 New	56,800 $458,000
Q1 2024 May 07, 2024	SELL	$2.94 - $4.24 $100,548 - $145,008	-34,200 Reduced 35.29%	62,700 $265,000
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $147,000 - $196,490	49,000 Added 102.3%	96,900 $364,000
Q3 2023 Nov 14, 2023	SELL	$3.6 - $4.46 $5,040 - $6,244	-1,400 Reduced 2.84%	47,900 $177,000
Q2 2023 Aug 11, 2023	SELL	$3.94 - $5.8 $189,908 - $279,560	-48,200 Reduced 49.44%	49,300 $195,000
Q1 2023 May 16, 2023	BUY	$3.22 - $4.61 $181,608 - $260,004	56,400 Added 137.23%	97,500 $403,000
Q4 2022 Feb 14, 2023	BUY	$2.81 - $4.45 $73,060 - $115,700	26,000 Added 172.19%	41,100 $173,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $12,126 - $32,335	4,300 Added 39.81%	15,100 $43,000
Q2 2022 Aug 15, 2022	SELL	$2.73 - $5.61 $87,360 - $179,520	-32,000 Reduced 74.77%	10,800 $43,000
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $39,066 - $63,648	10,200 Added 31.29%	42,800 $235,000
Q4 2021 Feb 14, 2022	SELL	$4.47 - $5.56 $196,233 - $244,083	-43,900 Reduced 57.39%	32,600 $148,000
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $199,808 - $318,528	-44,800 Reduced 36.93%	76,500 $356,000
Q2 2021 Aug 11, 2021	SELL	$6.05 - $10.09 $248,050 - $413,690	-41,000 Reduced 25.26%	121,300 $832,000
Q1 2021 May 17, 2021	BUY	$6.84 - $17.58 $832,428 - $2.14 Million	121,700 Added 299.75%	162,300 $1.62 Million
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $57,000 - $104,310	11,400 Added 39.04%	40,600 $302,000
Q3 2020 Nov 16, 2020	BUY	$3.96 - $6.15 $70,884 - $110,085	17,900 Added 158.41%	29,200 $176,000
Q2 2020 Aug 14, 2020	SELL	$3.08 - $6.56 $44,044 - $93,808	-14,300 Reduced 55.86%	11,300 $71,000
Q3 2019 Nov 14, 2019	SELL	$6.38 - $9.69 $590,788 - $897,294	-92,600 Reduced 78.34%	25,600 $163,000
Q2 2019 Aug 14, 2019	SELL	$5.93 - $10.57 $113,263 - $201,887	-19,100 Reduced 13.91%	118,200 $1.06 Million
Q1 2019 May 15, 2019	BUY	$6.95 - $13.25 $954,235 - $1.82 Million	137,300 New	137,300 $1.3 Million

Others Institutions Holding CRMD

# of Institutions

104

Shares Held

17.4M

Call Options Held

134K

Put Options Held

441K

Black Rock Inc. New York, NY

3.55M
Shares

$36.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.07M
Shares

$31.7 Million
0.0% of portfolio
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl

1.55M
Shares

$16 Million
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

1.28M
Shares

$13.3 Million
0.0% of portfolio
State Street Corp Boston, MA

1.23M
Shares

$12.7 Million
0.0% of portfolio

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account